Skip to Main Content
TRC_Tech_Canada
Menu
    • Products
      • CriticalPoint
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • NetCE All Access
      • NetCE All Access: Behaviorial Health
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber Insights
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Featured Charts & Graphics
    • Gender-Related Care
    • Natural Medicines Resources
    • All Charts & Graphics
  • Podcasts
  • Charts & Graphics
    • Featured Charts & Graphics
    • Do Not Crush List
    • New Drugs
    • Original Container Meds
    • All Charts & Graphics >
  • CE/CME & Training
    • CE Organizer
    • Available Courses
    • My Completions
    • Live Webinars
  • Help
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

  1. Home
  2. Browse
  3. Diabetes & Endocrinology
  4. Diabetes

Diabetes

  • Diabetes (599)
    • Blood Glucose Meters (7)
    • Complications (108)
    • Diabetes in Pregnancy (4)
    • Diabetes Meds (73)
    • Drug-Induced Hypo/Hyperglycemia (99)
    • Monitoring (86)
    • Natural Medicines/Supplements (11)
    • Prevention (26)
    • Treatment (217)
  • Endocrinology (10)
  • Hyperglycemia (25)
  • Hypoglycemia (23)
  • Other (21)
  • Prediabetes (2)
  • Resources (132)
  • Thyroid Disorders (51)
406 - 420 of 599 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Article: The new inhaled insulin, Exubera, is getting patients excited March 2006
Article: whether sulfonylureas increase mortality March 2006
Other: Glitazone-associated Macular Edema February 2006
Other: New Formulation: Avandaryl (Rosiglitazone and Glimepiride) February 2006
Article: new or worsening macular edema in diabetes patients taking rosiglitazone (Avandia, Avandamet) February 2006
Article: Avandaryl...a new combination of rosiglitazone and glimepiride February 2006
Article: Levemir (insulin detemir) is now available in Canada February 2006
Commentary: Niacin Use: An Update December 2005
Other: Heart Failure and Use of Metformin November 2005
Article: whether metformin is appropriate for diabetes patients with heart failure November 2005
Article: Actos (pioglitazone) reduces the risk of heart attack and stroke in some patients with type 2 diabetes October 2005
Other: The Prospective Pioglitazone Clinical Trial in Macrovascular Events Study (PROactive Study) October 2005
Article: two new investigational drugs for diabetes September 2005
Other: Investigational Drug: Muraglitazar (Pargluva) September 2005
Article: The many new insulins have people confused about which one to use August 2005
  • « Prev
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.



© Therapeutic Research Center. All Rights Reserved